Nanotechnology Now - Press Release: Nanostart-holding BioMers announces strategic tie-up in Europe

Home > Press > Nanostart-holding BioMers announces strategic tie-up in Europe

Abstract:
- Successful national roll-out of flagship product SimpliClear in the Spanish market
- Partnership with Vitaldent, Europe's largest dental chain, positions BioMers to establish leading presence in the European aesthetic orthodontic market

Nanostart-holding BioMers announces strategic tie-up in Europe

Frankfurt, Germany and Singapore | Posted on June 26th, 2013

Nanostart-holding BioMers Pte Ltd, a Singapore medical device company, announced today the successful completion of its flagship product's - SimpliClear - nationwide launch in Spain. The Spanish launch of the world's first completely clear braces materialized in partnership with Vitaldent, Europe's largest dental chain and one of the leading chains of clinics globally.
BioMers is now offering SimpliClear in all 380 clinics of Vitaldent throughout the country. The company has signed a five-year partnership agreement with Vitaldent and set up its European headquarters in Madrid, Spain.

Through these latest developments, BioMers is in its own terms positioning itself to play a leading role as a major innovator in the growing aesthetic orthodontic segment in Europe, which represents one-third of the global orthodontic market.

BioMers is a spin-off from the National University of Singapore and portfolio company of New Asia Investments, a Singapore-based venture capital firm. Nanostart AG holds an interest of approximately 30 percent in New Asia Investments.

####

About Nanostart AG
Nanostart AG is a leading nanotechnology venture capital company. The company invests venture capital (VC) in promising young nanotechnology companies. Nanostart invests globally and at different phases of development. Emphasis of investments is on especially innovative industries such as cleantech, life sciences, and IT/electronics. Nanostart invests either directly in nanotechnology companies or through a regional nanotechnology fund. The headquarters of Nanostart AG is in Frankfurt, Germany.

About BioMers

BioMers Pte. Ltd. is a Singapore-based medical device company that has developed novel polymer composite products for numerous biomedical applications. The company’s flagship product is the SimpliClear® braces system, which is the world’s first and only aesthetic solution for all types of orthodontic treatments. This translucent, almost invisible braces system is customized to each patient, providing faster and better results. Established in 2005, BioMers is a spin-off company from the National University of Singapore, where the technology was invented. BioMers has received seed funding from NUS Enterprise, venture capital funding from the Nanostart Singapore Early Stage Venture Fund, and grants from government agencies, including SPRING Singapore and the Economic Development Board. For more information, visit www.simpliclear.com.

Disclaimer

This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia, or Japan.

For more information, please click here

Contacts:
Nanostart AG
Dr. Hans Joachim Dürr
Head of Corporate Communications
Goethestrasse 26-28
60313 Frankfurt/Main
P: +49 69-21 93 96 111
F: +49 69-21 93 96 150

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: